Biohaven Pharmaceutical Holding Co Ltd.

GEODE CAPITAL MANAGEMENT, LLC

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

1,097,362

Value ($000)

165,888

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	165,888	0.0%	1,097,362	9/30/2022
2022 Q2	8/12/2022	156,219	0.0%	1,072,125	6/30/2022
2022 Q1	5/13/2022	119,116	0.0%	1,004,613	3/31/2022
2021 Q4	2/11/2022	132,447	0.0%	961,090	12/31/2021
2021 Q3	11/12/2021	130,432	0.0%	938,974	9/30/2021
2021 Q2	8/13/2021	88,677	0.0%	913,450	6/30/2021
2021 Q1	5/12/2021	55,810	0.0%	816,539	3/31/2021
2020 Q4	2/12/2021	63,133	0.0%	736,596	12/31/2020
2020 Q3	11/13/2020	45,033	0.0%	692,710	9/30/2020
2020 Q2	8/13/2020	47,999	0.0%	656,536	6/30/2020
2020 Q1	5/14/2020	20,645	0.0%	606,691	3/31/2020
2019 Q4	2/13/2020	28,189	0.0%	517,815	12/31/2019